IRON (Disc Medicine) Total Liabilities: $61.78 Mil (As of Mar. 2026)


IRON Disc Medicine Inc IRON
34 GF Score
Price $74.52
! 3 Warning Signs
View Full Analysis

What is Disc Medicine Total Liabilities?

Disc Medicine IRON -0.41% 34 Total Liabilities is $61.78 Mil as of Mar. 2026. GuruFocus rates IRON with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Disc Medicine's Total Liabilities for the quarter that ended in Mar. 2026 was $61.78 Mil.

Disc Medicine's quarterly Total Liabilities increased from Sep. 2025 ($57.07 Mil) to Dec. 2025 ($67.05 Mil) but then declined from Dec. 2025 ($67.05 Mil) to Mar. 2026 ($61.78 Mil).

Disc Medicine's annual Total Liabilities increased from Dec. 2023 ($22.88 Mil) to Dec. 2024 ($53.19 Mil) and increased from Dec. 2024 ($53.19 Mil) to Dec. 2025 ($67.05 Mil).

Disc Medicine Total Liabilities Historical Data

* Premium members only.

The historical data trend for Disc Medicine's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Disc Medicine Total Liabilities Chart

Disc Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 156.61 23.61 22.88 53.19 67.05

Disc Medicine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.90 50.90 57.07 67.05 61.78
IRON
34GF Score
Disc Medicine Inc IRON
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disc Medicine Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Disc Medicine's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=36.641+(30.412+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=67.05

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=806.879-739.826
=67.05

Disc Medicine's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=31.142+(30.642+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=61.78

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=750.213-688.429
=61.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $61.78 Mil mean?
Disc Medicine (IRON) has a Total Liabilities of $61.78 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Disc Medicine and its competitors.
Is Disc Medicine's Total Liabilities too high?
Disc Medicine's current Total Liabilities is $61.78 Mil. Overall, Disc Medicine has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Disc Medicine's Total Liabilities compare to CLDX and TARS?
Disc Medicine's Total Liabilities of $61.78 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Disc Medicine and its competitors. Disc Medicine's current Total Liabilities is $61.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disc Medicine stock overvalued right now?
Disc Medicine (IRON) has a current Total Liabilities of $61.78 Mil. The current Total Liabilities is $61.78 Mil. Disc Medicine's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Disc Medicine (IRON), the current Total Liabilities is $61.78 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Disc Medicine Business Description

Address 321 Arsenal Street, Suite 101, Watertown, MA, USA, 02472
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
34GF Score

Get the complete analysis for IRON

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$74.52
Price